# Regeneron Pharmaceuticals, Inc. – FDA Inspection, Jan 16, 2026

Source: https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/80f1263d-d05f-4449-b8b0-4d7778eba110
Source feed: FDA_Inspections

> FDA inspection 1291552 of Regeneron Pharmaceuticals, Inc., January 16, 2026. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1291552
- Company Name: Regeneron Pharmaceuticals, Inc.
- Inspection Date: 2026-01-16
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New York District Office
- Citation Count: 0

## Related Officers

- [Company Rep](https://www.keypedia.com/people/cassandra-l-abellard/e27aef11-adc6-449b-b7a8-f4c419549467)
- [Issuing Officer](https://www.keypedia.com/people/harriet-touret/4f5e6de3-1411-40b0-90b8-26a4719f5169)
- [Issuing Officer](https://www.keypedia.com/people/jangsong-bang/2876e106-a5fe-49fb-aa56-4b462d3293d8)
- [Issuing Officer](https://www.keypedia.com/people/jiangsong-jiang/055e81c4-48a9-423d-b90f-ea0d08df79e1)

Company: https://www.keypedia.com/companies/regeneron-pharmaceuticals-inc/6269d8ca-45cd-478d-ab7d-181ccba72353

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d
